Saniona AB (OSTO:SANION) Treasury Stock : kr0.00 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Saniona AB Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Saniona AB's treasury stock for the quarter that ended in Mar. 2024 was kr0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Saniona AB Treasury Stock Historical Data

The historical data trend for Saniona AB's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Saniona AB Treasury Stock Chart

Saniona AB Annual Data

Trend

Jan14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Treasury Stock

Get a 7-Day Free Trial

Saniona AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Treasury Stock	Get a 7-Day Free Trial															-	-	-	-	-

Saniona AB Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Saniona AB (OSTO:SANION) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Saniona AB (OSTO:SANION) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

30S:Germany

Address

Smedeland 26B, Glostrup, DNK, DK-2600

Website

https://www.saniona.com

Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219.

Saniona AB (OSTO:SANION) Headlines

No Headlines